Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Uri Clinton, Chief Legal Officer and Secretary of Boyd Gaming Corp. (NASDAQ: BYD), executed a sale of 3,468 shares on June 9, 2026, valued at $304,108. The transaction occurred at $87.69 per share, leaving Clinton with a direct holding of 56,818 shares. This insider activity coincides with the company trading near its 52-week high of $89.96, despit…
Thomas M. Constantine, Executive Vice President and Chief Credit Officer at Axos Financial, Inc. (NASDAQ: AX), executed a sale of 1,994 shares of the company's common stock on June 8, 2026. The transaction, valued at $176,574, occurred at prices ranging from $88.19 to $90.00 per share, with a weighted average price of $88.553. This sale brings Cons…
Crocs, Inc. (NASDAQ:CROX) Chief Executive Officer Andrew Rees executed a significant divestment of company equity, selling approximately $3.86 million worth of common stock on June 5, 2026. The transaction was facilitated through the REES FAMILY LIVING TRUST, which Rees manages as a trustee. The sale occurs against a backdrop of substantial share p…
United Therapeutics Corp (NASDAQ:UTHR) Chief Financial Officer and Treasurer James Edgemond executed a transaction involving the sale of 10,000 shares of the company's common stock on June 8, 2026. The sale, valued at approximately $5.48 million, was conducted pursuant to a pre-arranged Rule 10b5-1 trading plan established on October 31, 2025. Prio…
Charles Thomas McMillen, a director at Nexstar Media Group, Inc., executed a sale of 1,000 shares on June 9, 2026, totaling $180,000. This transaction occurred as the company's stock traded slightly above the sale price, reflecting a valuation metric that some analysts view as high relative to fair value. The sale comes shortly after Nexstar report…
Elite Health Systems Inc. CEO and director jeereddi Prasad Anjaneya has increased his stake in the company through two separate transactions totaling $12,600. The purchases, disclosed via SEC Form 4 filings, occurred at a consistent price point despite recent downward price action. This activity follows a period of significant market depreciation f…
Immunome Inc. (NASDAQ:IMNM) director Jean Jacques Bienaime executed a series of matched open-market transactions on June 5, 2026, involving the sale and subsequent reacquisition of 10,500 shares each. The simultaneous nature of these trades, which generated a minor short-swing profit, occurs against a backdrop of significant clinical and regulatory…
Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ: NBIX), executed a transaction involving the sale of 25,000 shares of common stock on June 5, 2026, generating approximately $4.13 million. The sale was conducted under a Rule 10b5-1 trading plan established earlier in the year. The transaction coincides with the stock trading ne…
Alset Inc., a significant shareholder in HWH International Inc., has executed a direct purchase of 250,000 newly issued shares of HWH International common stock. The transaction, valued at $500,000, occurs against a backdrop of HWH International's ongoing challenges with Nasdaq listing compliance. While the purchase price represents a substantial p…
Taira Thomas, President of Special Projects at CARVANA CO. (NASDAQ:CVNA), executed a sale of 5,597 shares of Class A Common Stock on June 8, 2026. The transaction, valued at $375,838, was conducted at $67.15 per share under a Rule 10b5-1 trading plan established in August 2025. Following the sale, Thomas retains a direct holding of 315,075 shares. …
Malik Fady Ibraham, Executive Vice President of Research & Development at Cytokinetics Incorporated (NASDAQ:CYTK), executed a series of equity transactions on June 9, 2026. The executive sold 3,500 shares for $237,930 following the exercise of non-qualified stock options. This activity occurs as Cytokinetics advances its cardiac myosin inhibitor, M…
Nina Capital Holdings Inc., a ten percent owner of PetMed Express Inc. (NASDAQ:PETS), has purchased an additional $43,725 worth of common stock. The acquisition occurred on June 8, 2026, involving 25,000 shares at a weighted average price of $1.749 per share. This purchase comes as the stock has experienced substantial declines over recent periods,…
BioCardia Inc. (NASDAQ: BCDA) President and CEO Peter Altman executed a stock purchase on June 9, 2026, acquiring 5,000 shares at $0.85 per share, totaling $4,250. This transaction occurred just above the stock's 52-week low of $0.84 and follows a period where the share price has declined 59% over the past year. Following the purchase, Altman's dir…
Matthew J. Cox, the Chairman and Chief Executive Officer of Matson, Inc., has executed a significant sale of company shares, offloading 9,900 shares on June 8, 2026. The transaction, valued at approximately $1.9 million, was conducted under a Rule 10b5-1 trading plan established in March of the same year. This executive activity coincides with Mats…
Laura L. Rascon, Senior Vice President at Matson, Inc. (NASDAQ:MATX), executed a series of stock transactions on June 8, 2026, divesting 2,800 shares valued at $527,897. The sale occurs as Matson's shares approach their 52-week peak of $192.62, reflecting a substantial 70% return over the past year. Despite the executive's liquidation, analysis sug…
Ichor Holdings CFO Greg Swyt sold 6,820 ordinary shares on June 8, 2026, totaling $455,644 at a weighted average price of $66.81 per share. The transaction occurred within a $65.29 to $68.24 price range and was executed under a Rule 10b5-1 trading plan adopted on February 26, 2026. Following the sale, Swyt retains direct ownership of 53,070 shares.…
James L. Cunniff, Chief Executive Officer and President of Electromed, Inc. (NASDAQ:ELMD), executed a sale of 9,700 shares of the company's common stock on June 8, 2026, realizing a total of $354,095. The transaction occurred shortly after Cunniff exercised employee stock options to acquire the same number of shares at $17.25 per share, totaling $1…
Sheri Savage, Chief Financial Officer of Ultra Clean Holdings, Inc. (NASDAQ: UCTT), executed a sale of 15,766 shares on June 4, 2026, totaling approximately $1,410,556. The sale occurred at prices ranging from $86.00 to $91.76 per share, resulting in a weighted average across multiple transactions. This activity comes as Ultra Clean Holdings' stock…
Jennifer N. Jones, Chief Accounting Officer of Coinbase Global, Inc. (NASDAQ: COIN), executed a direct sale of 2,051 shares of the company's Class A Common Stock on June 5, 2026, realizing proceeds totaling $324,365. The transaction was conducted at $158.15 per share and executed under a Rule 10b5-1 trading plan adopted by Jones on March 6, 2026, d…
Jon E. Bortz, Chairman and CEO of Pebblebrook Hotel Trust (NYSE:PEB), has acquired 40,000 common shares totaling approximately $678,600. The purchases were executed over two consecutive days, with share prices ranging from $16.84 to $17.09. This transaction occurs as PEB stock trades near its 52-week high of $17.23, following a 73% gain over the pa…
David Weiant, Senior Vice President at Provident Financial Holdings Inc. (NASDAQ: PROV), executed a transaction on June 8, 2026, selling 1,012 shares of the company's common stock for a total of $17,204. The sale occurred at a per-share price of $17.00, a level that places the stock in close proximity to its 52-week high of $17.42. This transaction…
Robert G. Pearse, a director at Star Equity Holdings, Inc. (NASDAQ:STRR), purchased 500 shares of the company's common stock on June 5, 2026. The transaction, valued at $5,730, saw shares acquired at prices ranging from $11.32 to $11.50 per share. The shares were acquired at a weighted average price of $11.46, slightly above the current stock price…
Control Empresarial de Capitales S.A. de C.V., a major shareholder in PBF Energy Inc. (NYSE:PBF), executed a sale of 100,000 Class A Common Shares on June 5, 2026, totaling $4,316,950. The transaction occurred at prices between $43.15 and $43.25 per share. This divestment follows a significant 130% surge in PBF's stock over the past year, though th…
MasterBrand, Inc. (NASDAQ:MBC) director David D. Petratis executed a direct purchase of 11,587 common shares on June 8, 2026, bringing his total direct holdings to 69,915 shares. The transaction occurs against a backdrop of near-term financial headwinds, as the company recently reported first-quarter earnings and revenue figures that fell short of …
Christopher R. Tangard, Senior Vice President and Chief Accounting Officer at Kinsale Capital Group, Inc. (NASDAQ:KNSL), executed a direct purchase of 330 shares on June 8, 2026, at $304.00 per share, bringing his total direct holdings to 2,883 shares. The transaction, valued at $100,320, adds to his indirect holdings of 380 shares held in a spousa…
